P F
1 Nov, 2024

Policies recently reviewed for annual update

The following policies were recently reviewed for annual update. The full texts of these policies are available in the Provider section of bcbsri.com:

  • Artificial Pancreas Device System
  • Bone Mineral Density Studies
  • Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management (Liquid Biopsy)
  • Cryosurgical Ablation of Miscellaneous Solid Tumors other than Renal, Liver and Prostate
  • Digital Health Technologies for Attention Deficit Hyperactivity Disorder
  • Digital Health Technologies - Diagnostic Applications
  • Digital Health Technologies - Therapeutic Applications
  • Dynamic Spinal Visualization and Vertebral Motion Analysis
  • Gender Affirming Care
  • Gene Therapies for Duchenne Muscular Dystrophy
  • Low-Level Laser Therapy
  • Navigated Transcranial Magnetic Stimulation
  • Preimplantation Genetic Testing
  • Prostatic Urethral Lift
  • Radiofrequency Ablation of Miscellaneous Solid Tumors Excluding Liver Tumors
  • Risk Reducing Mastectomy
  • Saturation Biopsy for Diagnosis, Staging and Management of Prostate Cancer
  • Scintimammography and Gamma Imaging of the Breast and Axilla
  • Thermography
  • Uterus Transplantation for Absolute Uterine Factor Infertility
  • Whole Gland Cryoablation of Prostate

We also post monthly drafts of medical policies being created or reassessed for your review. As a reminder, you can provide comments on draft policies for up to 30 days. Draft policies are located on the Provider homepage, under the Medical Policies section, under the “Draft Medical Policies" drop-down.